TY - JOUR
T1 - Novel risk loci identified in a genome-wide association study of urolithiasis in a Japanese population
AU - Tanikawa, Chizu
AU - Kamatani, Yoichiro
AU - Terao, Chikashi
AU - Usami, Masayuki
AU - Takahashi, Atsushi
AU - Momozawa, Yukihide
AU - Suzuki, Kichiya
AU - Ogishima, Soichi
AU - Shimizu, Atsushi
AU - Satoh, Mamoru
AU - Matsuo, Keitaro
AU - Mikami, Haruo
AU - Naito, Mariko
AU - Wakai, Kenji
AU - Yamaji, Taiki
AU - Sawada, Norie
AU - Iwasaki, Motoki
AU - Tsugane, Shoichiro
AU - Kohri, Kenjiro
AU - Yu, Alan S.L.
AU - Yasui, Takahiro
AU - Murakami, Yoshinori
AU - Kubo, Michiaki
AU - Matsuda, Koichi
N1 - Publisher Copyright:
Copyright © 2019 by the American Society of Nephrology
PY - 2019/5
Y1 - 2019/5
N2 - Background A family history of urolithiasis is associated with a more than doubling of urolithiasis risk, and a twin study estimating 56% heritability of the condition suggests a pivotal role for host genetic factors. However, previous genome-wide association studies (GWAS) have identified only six risk-related loci. Methods To identify novel urolithiasis-related loci in the Japanese population, we performed a large-scale GWAS of 11,130 cases and 187,639 controls, followed by a replication analysis of 2289 cases and 3817 controls. Diagnosis of urolithiasis was confirmed either by a clinician or using medical records or self-report. We also assessed the association of urolithiasis loci with 16 quantitative traits, including metabolic, kidney-related, and electrolyte traits (such as body mass index, lipid storage, eGFR, serum uric acid, and serum calcium), using up to 160,000 samples from BioBank Japan. Results The analysis identified 14 significant loci, including nine novel loci. Ten regions showed a significant association with at least one quantitative trait, including metabolic, kidney-related, and electrolyte traits, suggesting a common genetic basis for urolithiasis and these quantitative traits. Four novel loci were related to metabolic traits, obesity, hypertriglyceridemia, or hyperuricemia. The remaining ten loci were associated with kidney- or electrolyte-related traits; these may affect crystallization. Weighted genetic risk score analysis indicated that the highest risk group (top 20%) showed an odds ratio of 1.71 (95% confidence interval, 1.42 to 2.06) - 2.13 (95% confidence interval, 2.00 to 2.27) compared with the reference group (bottom 20%). Conclusions Our findings provide evidence that host genetic factors related to regulation of metabolic and crystallization pathways contribute to the development of urolithiasis.
AB - Background A family history of urolithiasis is associated with a more than doubling of urolithiasis risk, and a twin study estimating 56% heritability of the condition suggests a pivotal role for host genetic factors. However, previous genome-wide association studies (GWAS) have identified only six risk-related loci. Methods To identify novel urolithiasis-related loci in the Japanese population, we performed a large-scale GWAS of 11,130 cases and 187,639 controls, followed by a replication analysis of 2289 cases and 3817 controls. Diagnosis of urolithiasis was confirmed either by a clinician or using medical records or self-report. We also assessed the association of urolithiasis loci with 16 quantitative traits, including metabolic, kidney-related, and electrolyte traits (such as body mass index, lipid storage, eGFR, serum uric acid, and serum calcium), using up to 160,000 samples from BioBank Japan. Results The analysis identified 14 significant loci, including nine novel loci. Ten regions showed a significant association with at least one quantitative trait, including metabolic, kidney-related, and electrolyte traits, suggesting a common genetic basis for urolithiasis and these quantitative traits. Four novel loci were related to metabolic traits, obesity, hypertriglyceridemia, or hyperuricemia. The remaining ten loci were associated with kidney- or electrolyte-related traits; these may affect crystallization. Weighted genetic risk score analysis indicated that the highest risk group (top 20%) showed an odds ratio of 1.71 (95% confidence interval, 1.42 to 2.06) - 2.13 (95% confidence interval, 2.00 to 2.27) compared with the reference group (bottom 20%). Conclusions Our findings provide evidence that host genetic factors related to regulation of metabolic and crystallization pathways contribute to the development of urolithiasis.
UR - http://www.scopus.com/inward/record.url?scp=85065508520&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85065508520&partnerID=8YFLogxK
U2 - 10.1681/ASN.2018090942
DO - 10.1681/ASN.2018090942
M3 - Article
C2 - 30975718
AN - SCOPUS:85065508520
SN - 1046-6673
VL - 30
SP - 855
EP - 864
JO - Journal of the American Society of Nephrology
JF - Journal of the American Society of Nephrology
IS - 5
ER -